Regulating AI-Based Medical Devices in Saudi Arabia: New Legal Paradigms in an Evolving Global Legal Order
<p dir="ltr">This paper examines the Saudi Food and Drug Authority’s (SFDA) Guidance on Artificial Intelligence (AI) and Machine Learning (ML) technologies based Medical Devices (the MDS-G010). The SFDA has pioneered binding requirements designed for manufacturers to obtain Medical D...
Saved in:
| Main Author: | Barry Solaiman (19160614) (author) |
|---|---|
| Published: |
2024
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Monitoring Mental Health: Legal and Ethical Considerations of Using Artificial Intelligence in Psychiatric Wards
by: Barry Solaiman (19160614)
Published: (2024) -
Generative artificial intelligence (GenAI) and decision-making: Legal & ethical hurdles for implementation in mental health
by: Barry Solaiman (19160614)
Published: (2024) -
Legal and Ethical Considerations of Artificial Intelligence for Residents in Post-Acute and Long-Term Care
by: Barry Solaiman (19160614)
Published: (2024) -
Regulating algorithmic care in the European Union: evolving doctor–patient models through the Artificial Intelligence Act (AI-Act) and the liability directives
by: Barry Solaiman (19160614)
Published: (2024) -
Generative AI and the Metaverse: A Scoping Review of Ethical and Legal Challenges
by: Aliya Tabassum (16896486)
Published: (2025)